US Stock MarketDetailed Quotes
IART Integra Lifesciences
- 24.810
- -0.640-2.51%
Close Nov 12 16:00 ET
- 24.810
- 0.0000.00%
Post 17:35 ET
1.91BMarket Cap-275666P/E (TTM)
25.520High24.740Low1.11MVolume25.200Open25.450Pre Close27.72MTurnover1.68%Turnover Ratio29.54P/E (Static)77.16MShares45.42052wk High1.26P/B1.64BFloat Cap16.80552wk Low--Dividend TTM66.02MShs Float77.400Historical High--Div YieldTTM3.07%Amplitude1.500Historical Low25.013Avg Price1Lot Size
Integra Lifesciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -16.01%22.49M | 42.87%40.4M | -39.76%15.76M | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M | -15.35%264.47M | 23.18%85.33M |
| Net income from continuing operations | -154.86%-10.7M | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M |
| Operating gains losses | -28.00%72K | 1,646.91%1.25M | 152.17%12K | 110.42%777K | 110.11%781K | 121.65%100K | -505.00%-81K | -103.23%-23K | 81.15%-7.46M | -2,133.42%-7.73M |
| Depreciation and amortization | 17.68%35.96M | 19.31%36.78M | -1.85%30.57M | 4.41%123.51M | 5.05%30.99M | 3.70%30.56M | 4.10%30.83M | 4.77%31.14M | -1.28%118.3M | -4.07%29.5M |
| Deferred tax | -831.04%-9.04M | -712.33%-1.84M | -246.24%-2.86M | -159.21%-11.89M | -146.48%-14.85M | 120.27%1.24M | -105.68%-227K | -44.89%1.95M | -66.42%-4.59M | -156.07%-6.02M |
| Other non cash items | -140.50%-1.61M | 1.76%3.36M | -74.48%2M | 299.58%21.24M | 831.71%6.11M | 138.73%3.98M | 268.56%3.3M | 733.23%7.85M | -222.31%-10.64M | -21.81%656K |
| Change In working capital | 109.96%3.39M | 106.26%938K | 45.20%-23.35M | -106.94%-81.57M | -1.59%10.09M | -969.18%-34.06M | 10.34%-14.99M | -43.14%-42.61M | -317.03%-39.42M | 140.62%10.26M |
| -Change in receivables | 12,734.82%28.75M | -28.78%-6.72M | 67.58%16.83M | 113.55%4.59M | 95.45%-457K | 101.57%224K | 19.97%-5.22M | 422.24%10.04M | -566.69%-33.91M | 1.35%-10.04M |
| -Change in inventory | 34.78%-10.3M | 181.75%1.74M | 25.18%-19.02M | -105.24%-59.77M | -250.84%-16.42M | -130.01%-15.8M | 64.56%-2.13M | -119.90%-25.42M | -641.94%-29.12M | -152.17%-4.68M |
| -Change in prepaid assets | -57.56%-17.63M | -68.87%-14.1M | -23.66%-2.68M | -69.21%2.65M | 248.73%24.35M | -294.61%-11.19M | -1,001.51%-8.35M | 57.11%-2.16M | 140.73%8.61M | 173.92%6.98M |
| -Change in payables and accrued expense | 209.36%6.83M | 238.07%15.07M | -285.43%-19.21M | -216.64%-20.23M | -89.46%1.91M | -145.39%-6.24M | -127.30%-10.92M | 48.90%-4.98M | -47.24%17.34M | 1,944.11%18.15M |
| -Change in other current assets | -1,809.49%-11.27M | 522.16%9.18M | 105.64%339K | -291.15%-8.54M | 102.03%239K | -120.80%-590K | -148.82%-2.18M | -363.21%-6.01M | -127.71%-2.18M | -695.29%-11.76M |
| -Change in other current liabilities | 6,590.00%7.36M | -158.60%-7.91M | 113.02%1.89M | 90.76%-410K | -95.10%483K | 101.78%110K | 343.59%13.5M | -463.00%-14.5M | 68.55%-4.44M | 163.06%9.85M |
| -Change in other working capital | 40.48%-347K | 1,147.28%3.67M | -448.37%-1.5M | -97.01%128K | -100.74%-13K | -133.31%-583K | --294K | --430K | 15,164.29%4.27M | --1.75M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -16.01%22.49M | 42.87%40.4M | -39.76%15.76M | -47.08%139.96M | -31.15%58.75M | -60.81%26.77M | -57.46%28.28M | -41.02%26.16M | -15.35%264.47M | 23.18%85.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -35.07%-10.4M | -1,972.28%-322.2M | -293.79%-53.97M | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M | 63.71%-58.58M | -99.45%-54.82M |
| Net PPE purchase and sale | -126.69%-29.65M | -91.07%-29.71M | -12.85%-15.47M | -114.32%-66.87M | -641.01%-24.54M | -42.85%-13.08M | -65.28%-15.55M | -46.96%-13.7M | 35.03%-31.2M | 87.93%-3.31M |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -8,075.86%-4.74M | --0 |
| Net business purchase and sale | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 75.72%-27.55M | ---51.51M |
| Net investment purchase and sale | 257.74%19.25M | ---10.5M | ---38.5M | -656.39%-27.31M | ---32.69M | --5.38M | --0 | --0 | 6,359.21%4.91M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -35.07%-10.4M | -1,972.28%-322.2M | -293.79%-53.97M | -60.77%-94.18M | -4.39%-57.23M | -151.99%-7.7M | -245.66%-15.55M | 2.58%-13.7M | 63.71%-58.58M | -99.45%-54.82M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 59.90%-19.92M | -776.72%-93.75M | 320.48%358.68M | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M | -156.50%-251.95M | -18,852.21%-97.7M |
| Net issuance payments of debt | -126.36%-19.74M | -171.32%-31.74M | 16,254.55%355.4M | 150.56%54.5M | 93.58%-6.5M | 1,252.31%74.9M | -2,440.00%-11.7M | -340.00%-2.2M | -7.80%-107.8M | -12,762.50%-101.3M |
| Net common stock issuance | --0 | ---50M | --0 | -120.00%-275M | --0 | ---125M | --0 | -20.00%-150M | ---125M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | 175.06%6.4M | -21.01%4.32M | -94.19%225K | --655K | 214.73%1.11M | 87.73%2.33M | -19.92%5.47M | 1,541.10%3.87M |
| Net other financing activities | 20.09%-171K | -11,442.31%-12M | 75.63%-3.12M | 44.18%-13.74M | -126.10%-615K | 81.26%-214K | 99.26%-104K | -39.17%-12.81M | -387.49%-24.62M | 47.18%-272K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 59.90%-19.92M | -776.72%-93.75M | 320.48%358.68M | 8.74%-229.93M | 92.95%-6.89M | -549.82%-49.66M | 18.67%-10.69M | -21.89%-162.68M | -156.50%-251.95M | -18,852.21%-97.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -30.39%215.24M | 92.57%591.91M | -39.47%276.4M | -11.06%456.66M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M | -11.06%456.66M | 9.21%513.45M | 8.87%511.94M |
| Current changes in cash | 74.41%-7.83M | -18,527.13%-375.55M | 313.32%320.47M | -299.77%-184.15M | 92.01%-5.37M | -140.52%-30.59M | -95.83%2.04M | -45.59%-150.23M | -187.31%-46.06M | -258.78%-67.19M |
| Effect of exchange rate changes | 258.95%7.75M | -428.17%-1.13M | -629.67%-4.96M | 136.27%3.89M | -32.50%8.04M | 54.41%-4.87M | 97.57%-213K | 129.58%937K | -13.16%-10.72M | 1,217.37%11.91M |
| End cash Position | -21.40%215.16M | -30.39%215.24M | 92.57%591.91M | -39.47%276.4M | -39.47%276.4M | -46.53%273.73M | -30.85%309.19M | -24.50%307.37M | -11.06%456.66M | -11.06%456.66M |
| Free cash flow | -152.30%-7.16M | -16.00%10.69M | -97.66%291K | -66.38%73.09M | -51.73%34.22M | -76.86%13.69M | -77.69%12.73M | -58.87%12.45M | -17.77%217.38M | 69.60%70.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
